comparemela.com

Latest Breaking News On - Australian stock exchange rce ax - Page 1 : comparemela.com

Recce Pharmaceuticals Completes Stage 1 Data Analysis of

Patients with bacterial infections successfully treated with RECCE® 327 (R327)Deadly bacterial pathogens treated with R327 include those identified by the.

Sydney
New-south-wales
Australia
United-states
Australian
Andrew-geddes
Jordyn-temperato
James-graham
Guillame-van-renterghem
Therapeutic-goods-administration
Lifesci-communications
World-health-organization-priority-pathogen

Recce Pharmaceuticals Achieves Positive Phase I Clinical

Highlights: Independent examiners confirm Phase I study of RECCE® 327 (R327) in 80 human subjects across eight cohorts achieved all primary study.

United-states
Australia
Sydney
New-south-wales
John-prendergast
Jordyn-temperato
Andrew-geddes
Alanw-dunton
James-graham
Guillame-van-renterghem
Therapeutic-goods-administration
Recce-pharmaceuticals-ltd

Recce Pharmaceuticals Announces RECCE® Trademark Registered

SYDNEY, Australia, Feb. 03, 2023 (GLOBE NEWSWIRE) Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of.

China
Australia
Japan
United-states
Hong-kong
Sydney
New-south-wales
Andrew-geddes
James-graham
Jordyn-temperato
Lifesci-communications
Recce-pharmaceuticals-ltd

Recce Pharmaceuticals Announces Preclinical SARS-CoV-2

Highlights: RECCE® 327 (R327) was shown to significantly reduce SARS-CoV-2 levels in hamsters, the gold-standard in COVID-19 preclinical animal modelsNew.

Australian-stock-exchange-rce-ax
Recce-pharmaceuticals

vimarsana © 2020. All Rights Reserved.